HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective Effect of Low-Molecular-Weight Fucoidan on Radiation-Induced Fibrosis Through TGF-β1/Smad Pathway-Mediated Inhibition of Collagen I Accumulation.

Abstract
Radiation-induced fibrosis (RIF) occurs after radiation therapy in normal tissues due to excessive production and deposition of extracellular matrix proteins and collagen, possibly resulting in organ function impairment. This study investigates the effects of low-molecular-weight fucoidan (LMF) on irradiated NIH3T3 cells. Specifically, we quantified cellular metabolic activity, fibrosis-related mRNA expression, transforming growth factor beta-1 (TGF-β1), and collagen-1 protein expression, and fibroblast contractility in response to LMF. LMF pre + post-treatment could more effectively increase cellular metabolic activity compared with LMF post-treatment. LMF pre + post-treatment inhibited TGF-β1 expression, which mediates negative activation of phosphorylated Smad3 (pSmad3) and Smad4 complex formation and suppresses downstream collagen I accumulation. In addition, LMF pre + post-treatment significantly reduced actin-stress fibers in irradiated NIH3T3 cells. LMF, a natural substance obtained from brown seaweed, may be a candidate agent for preventing or inhibiting RIF.
AuthorsSzu-Yuan Wu, Yu-Ting Chen, Guo-Yu Tsai, Fu-Yin Hsu, Pai-An Hwang
JournalMarine drugs (Mar Drugs) Vol. 18 Issue 3 (Feb 27 2020) ISSN: 1660-3397 [Electronic] Switzerland
PMID32120789 (Publication Type: Journal Article)
Chemical References
  • Polysaccharides
  • Protective Agents
  • Smad3 Protein
  • Transforming Growth Factor beta
  • Collagen
  • fucoidan
Topics
  • Animals
  • Collagen (metabolism)
  • Mice
  • NIH 3T3 Cells (drug effects)
  • Polysaccharides (pharmacology)
  • Protective Agents (pharmacology)
  • Radiation Pneumonitis (prevention & control)
  • Signal Transduction
  • Smad3 Protein (metabolism)
  • Transforming Growth Factor beta (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: